LEXINGTON, Mass.--(BUSINESS WIRE)--Feb. 1, 2006--Cubist Pharmaceuticals, Inc. (Nasdaq: CBST) today announced that senior management will present at two February investor conferences. On Wednesday, February 8th, at 8:00 A.M. ET, David McGirr, SVP and CFO will present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference "Innovation Meets Economics" being held at the Grand Hyatt New York Hotel. On Wednesday, February 15th, at 11:30 A.M. ET, Michael Bonney, President and CEO will present at the Bio CEO and Investor Conference "Investing in Biotechnology: The Value, The Risks, The Rewards" being held at the Waldorf=Astoria Hotel in New York City. Both presentations will include a discussion of the company's business activities, financial outlook, and current news.
